Inergetics,Inc. (OTCBB: NRTI), a world-class developer of nutritional supplements, announced that it had held a meeting of its Scientific/Medical Advisory Board to discuss product development and other preparations for the launch of its new CBD-based product line. The advisory board helps guide the formulation of the natural Cannabidiol (CBD)-based nutritional supplement line that Inergetics is planning to bring to market next year.

During the meeting, senior Inergetics executives discussed with the members of the Scientific/Medical Advisory Board the progress being made toward the launch of the company’s “first-to-market” line of CBD-based supplement.

“The pain relief category has long lacked an effective, non-opiate way of providing pain relief and we intend to transform the category with pain remedies that are holistic, natural, opiate-free and empowering to the patient and consumer,” said Mike James, CEO of Inergetics. “Our vision is to give hope to those who suffer from pain through new CBD-based solutions that are grounded in our demonstrated ability to produce innovative nutritional supplements.”

“This line will help consumers address pain and take back control of their lives without the risk of addiction and side effects associated with opiate-based and other pain drugs,” continued Mr. James. “Our revolutionary new solution will harness the therapeutic powers of cannabinoids, which have been within mankind’s physiological make-up since the beginning of time to help preserve the species. We could not be more excited about introducing our transformational line of CBD-based nutritional supplements to physicians, their patients and our stakeholders in 2015.”

Inergetics will be releasing its new CBD-based product line in medical marijuana dispensaries affiliated with Terra Tech in 2015. Continued updates on the CBD product initiative and the Scientific/Medical Advisory Board will be made available at